For diabetics, artificial pancreas finally arrives - or does it really?

Last week, the U.S. FDA approved the first-generation artificial pancreas system developed by Medtronic Inc. The system, dubbed MiniMed 530G, incorporates a threshold suspend automation, which automatically ceases insulin delivery and sounds an alarm if blood glucose level reaches a threshold pre...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

Recovering COVID-19 patients may face higher risk of developing blood clots

News Commentary | April 14, 2021

Scientists at Singapore's Nanyang Technological University reported that recovering COVID‑19 patients with preexisting cardiovascular conditions may be at a higher risk of developing blood clots. The findings come at a time when vaccines from AstraZeneca and Johnson & Johnson have reported rare ... Not part of subscription

The continuous glucose monitoring pricing dilemma for Type 2 diabetes

Case Study | May 14, 2021

Kaiser Health News recently published an article calling into question the efficacy of minimally invasive continuous glucose monitoring (CGM) solutions for non‑insulin‑treated Type 2 diabetic patients. These CGM solutions are inserted under the skin and typically measure interstitial glucose levels... Not part of subscription

Royal Philips begins clinical trials for first at-home ECG solution

News Commentary | February 07, 2022

Philips' device will be the industry's first attempt at an at‑home, 12‑lead ECG (electrocardiogram). It will include access to Philips' cardiac monitoring portfolio, which pairs cloud‑based data collection with data readings it claims are comparable to clinical ECGs. While the solution is still in ... Not part of subscription